+351 211 369 829 
People’s Choice Award goes to Ophiomics
We are very proud to announce that Ophiomics is the winner for the “People’s Choice Award”!This award was announced on the Scale Up Portuga
Ophiomics present in Web Summit
Road 2 Web Summit (R2WS) has elected Ophiomics to be one of the selected portuguese Startups to have free access to this year’s edition of Web Sum
Short listed for Portugal’s top Scale Ups
Ophiomics was short listed as one of the top 25 scale ups in Portugal 2020! Thank you BGI for your efforts in putting together the Scale Up Report eve
Ophiomics in the News – Jornal Económico
You can read the text in Portuguese or in English.
Ophiomics wins the 2020 Everis Award – Portugal
Great News! Ophiomics just won the Everis Award – Portugal, and is now in the final stage of the competition to the International Everis A
MEET OUR NEW TEAM
Ophiomics is growing! We are very happy to have onboard new team members that bring expertise in strategic fields. Our team will be focused on devel
OPHIOMICS NEW OFFICE IN LISBON
We have moved to a new location at Lispolis (Lisbon’s Technological Park), a strategic location for technological and innovative companies in Lisbon
Ophiomics gains an Ethics Mentor
As part of its development of new diagnostic and prognostic solutions for liver cancer, Ophiomics conducts research using data from patients, and cond
Ophiomics wins the EIC Accelerator Pilot scheme
Ophiomics wins EIC accelerator funding in its pilot scheme. This hybrid funding scheme that includes a grant together with investment from the Eu
Article in Health Europa about HepatoPredict
Health Europa, a publisher of digital content on Health issue sin Europe and beyond, published a feature about Ophiomics and HepatoPredict in its Heal
Ophiomics wins the SME Instrument Phase I
Ophiomics was granted the SME Instrument Phase I grant to conduct a Feasibility study for its HepatoPredict genomic signature for Liver Cancer. Check